COGT
Cogent Biosciences Inc
32.30$
+2.8%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -7.1% | +34.3% | +1.3% | +1.6% | +1.0% | +2.7% | +1.7% | -0.9% | -0.5% | +1.2% | -35.8% | – | |
| – | +1.1% | +6.1% | +6.6% | +3.5% | -3.7% | +0.3% | -2.9% | +9.1% | +48.5% | +7.3% | +1.2% | – | |
| – | -28.2% | -165.6% | – | +420.0% | -108.4% | – | – | -39.2% | -97.2% | -5,272.0% | – | – | |
| – | +160.3% | -77.8% | +111.4% | +89.2% | -73.2% | +629.3% | -76.1% | -50.4% | +1,147.7% | -44.6% | -17.6% | – | |
| – | – | -90.0% | -8,205.8% | – | +2.5% | +12.5% | -87.2% | -1,840.1% | +108.2% | -88.7% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +0.0% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | -100.0% | – | -100.1% | – | -95.8% | +95,938.5% | +89.1% | +360.3% | +170.8% | -91.1% | -94.4% | – | |
| – | – | – | -178.5% | – | -87.3% | +2,385.5% | -94.3% | -244.3% | – | -137.9% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.